首页|期刊导航|中华灾害救援医学|尿毒症合并急性心肌梗死患者应用连续性肾脏替代治疗的临床研究

尿毒症合并急性心肌梗死患者应用连续性肾脏替代治疗的临床研究OA

Clinical study on the application of continuous renal replacement therapy in uremic patients complicated with acute myocardial infarction

中文摘要英文摘要

目的 探讨连续性肾脏替代治疗在尿毒症合并急性心肌梗死治疗中的临床效果.方法 回顾性收集2019年1月至2025年1月北京大学首钢医院采用常规治疗联合间断肾脏替代治疗的40例尿毒症合并急性心肌梗死患者资料,纳入对照组;根据组间信息均衡原则,通过倾向性评分匹配法进行1∶1匹配,筛选出同期采用常规治疗联合连续性肾脏替代治疗的40例尿毒症合并急性心肌梗死患者资料,纳入观察组.比较两组治疗前后心功能指标、肾功能指标、炎症因子水平及并发症情况.结果 治疗7d,两组总超滤量比较,差异无统计学意义(P>0.05).两组左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、肾功能指标均低于治疗前,左室射血分数(LVEF)均高于治疗前,且观察组LVESD、LVEDD、肾功能指标水平低于对照组,LVEF水平高于对照组(P<0.05).两组血清炎症因子水平均低于治疗前,且观察组低于对照组(P<0.05).两组并发症比较,差异无统计学意义(P>0.05).结论 连续性肾脏替代治疗在尿毒症合并急性心肌梗死中应用,可更好地改善患者心功能和肾功能,减轻炎症反应,且安全性好.

Objective To explore the clinical effect of continuous renal replacement therapy in the treatment of uremia complicated with acute myocardial infarction(AMI).Methods A retrospective study was conducted.Data of 40 patients with uremia complicated with AMI who received conventional treatment combined with intermittent renal replacement therapy in Shougang Hospital of Peking University from January 2019 to January 2025 were collected and included in the control group.According to the principle of information balance between groups,a 1:1 matching was conducted through the propensity score matching method.The data of 40 patients with uremia complicated with AMI who received conventional treatment combined with continuous renal replacement therapy during the same period were screened out and included in the observation group.The cardiac function indicators,renal function indicators,levels of inflammatory factors and complications before and after treatment were compared between the two groups.Results After 7 days of treatment,there was no statistical significant difference in total ultrafiltration volume between the two groups(P>0.05).After 7 days of treatment,the left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD),and renal function indicators in both groups were lower than those before treatment,while the left ventricular ejection fraction(LVEF)was higher than that before treatment.Moreover,the LVESD,LVEDD,and renal function indicators in the observation group were lower than those in the control group,and the LVEF was higher than that in the control group(P<0.05).After 7 days of treatment,the levels of serum inflammatory factors in both groups were lower than those before treatment,and the levels in the observation group were lower than those in the control group(P<0.05).There was no statistically significant difference in complications between the two groups(P>0.05).Conclusion The application of continuous renal replacement therapy in uremia complicated with AMI can better improve the cardiac and renal functions of patients,reduce inflammatory responses,and has good safety.

王超;李峻岭;赵海丹

北京大学首钢医院肾内科,北京 100144北京大学首钢医院肾内科,北京 100144北京大学首钢医院肾内科,北京 100144

尿毒症急性心肌梗死连续性肾脏替代治疗

uremiaacute myocardial infarctionrenal replacement therapy

《中华灾害救援医学》 2026 (4)

403-408,6

10.13919/j.issn.2095-6274.ZHJY20260407

评论